口服环磷酰胺联合普萘洛尔有效治疗内脏转移性血管肉瘤。 - Suppr

Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.

作者信息

Daguzé Justine, Saint-Jean Mélanie, Peuvrel Lucie, Cassagnau Elisabeth, Quéreux Gaëlle, Khammari Amir, Dréno Brigitte

机构信息

Department of Dermatology, Hôtel-Dieu University Hospital, Nantes, France.

Department of Dermatology, Hôtel-Dieu University Hospital, Nantes, France; Inserm U 892, CIC, Hôtel-Dieu, Nantes, France.

出版信息

JAAD Case Rep. 2016 Dec 7;2(6):497-499. doi: 10.1016/j.jdcr.2016.10.005. eCollection 2016 Nov.

DOI:10.1016/j.jdcr.2016.10.005

PMID:28004027

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5161779/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d088/5161779/f692661f5f1a/gr1.jpg

相似文献

Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.

JAAD Case Rep. 2016 Dec 7;2(6):497-499. doi: 10.1016/j.jdcr.2016.10.005. eCollection 2016 Nov.

Large nose angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e52-e54. doi: 10.1111/jdv.14528. Epub 2017 Sep 6.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Ecancermedicalscience. 2015 Jan 8;9:499. doi: 10.3332/ecancer.2015.499. eCollection 2015.

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.

EBioMedicine. 2016 Apr;6:87-95. doi: 10.1016/j.ebiom.2016.02.026. Epub 2016 Feb 17.

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.

Oncoscience. 2018 Oct 11;5(9-10):264-268. doi: 10.18632/oncoscience.472. eCollection 2018 Sep.

Tandem autotransplantation for the treatment of metastatic breast cancer.

J Clin Oncol. 1995 Aug;13(8):2050-5. doi: 10.1200/JCO.1995.13.8.2050.

Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.

J Cancer Res Clin Oncol. 1988;114(3):301-5. doi: 10.1007/BF00405838.

Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.

Nephron. 2017;135(2):87-96. doi: 10.1159/000448291. Epub 2016 Dec 15.

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer.

Breast Cancer Res Treat. 1995 Apr;34(1):15-24. doi: 10.1007/BF00666487.

CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.

Cancer Chemother Pharmacol. 1984;13(2):142-4. doi: 10.1007/BF00257133.

引用本文的文献

Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study.

Res Sq. 2025 May 5:rs.3.rs-6573099. doi: 10.21203/rs.3.rs-6573099/v1.

Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma.

Open Vet J. 2023 Jun;13(6):801-806. doi: 10.5455/OVJ.2023.v13.i6.15. Epub 2023 Jun 25.

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

Front Oncol. 2022 Sep 15;12:940582. doi: 10.3389/fonc.2022.940582. eCollection 2022.

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux.

Front Oncol. 2021 Feb 1;10:614288. doi: 10.3389/fonc.2020.614288. eCollection 2020.

Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma.

Cureus. 2020 Dec 24;12(12):e12262. doi: 10.7759/cureus.12262.

PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.

BMJ Open. 2020 Sep 10;10(9):e039449. doi: 10.1136/bmjopen-2020-039449.

β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P modulation.

Oncogene. 2020 Jan;39(2):368-384. doi: 10.1038/s41388-019-0993-1. Epub 2019 Sep 2.

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.

Biomed J. 2019 Jun;42(3):155-165. doi: 10.1016/j.bj.2019.02.003. Epub 2019 Jul 25.

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.

Oncoscience. 2018 Oct 11;5(9-10):264-268. doi: 10.18632/oncoscience.472. eCollection 2018 Sep.

Propranolol for the treatment of vascular sarcomas.

J Exp Pharmacol. 2018 Sep 6;10:51-58. doi: 10.2147/JEP.S146211. eCollection 2018.

本文引用的文献

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.

EBioMedicine. 2016 Apr;6:87-95. doi: 10.1016/j.ebiom.2016.02.026. Epub 2016 Feb 17.

Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.

JAMA Dermatol. 2015 Nov;151(11):1226-9. doi: 10.1001/jamadermatol.2015.2554.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Ecancermedicalscience. 2015 Jan 8;9:499. doi: 10.3332/ecancer.2015.499. eCollection 2015.

Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.

PLoS One. 2013;8(3):e60021. doi: 10.1371/journal.pone.0060021. Epub 2013 Mar 28.

β-Adrenergic receptor expression in vascular tumors.

Mod Pathol. 2012 Nov;25(11):1446-51. doi: 10.1038/modpathol.2012.108. Epub 2012 Jun 29.

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.

Oncotarget. 2011 Oct;2(10):797-809. doi: 10.18632/oncotarget.343.

Angiosarcoma.

Lancet Oncol. 2010 Oct;11(10):983-91. doi: 10.1016/S1470-2045(10)70023-1. Epub 2010 May 25.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.

A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.

Cancer J. 2005 May-Jun;11(3):241-7. doi: 10.1097/00130404-200505000-00011.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献